We’re on a mission to find new potential treatment options for AL amyloidosis.

See if you may qualify

We are currently enrolling adults 18 years of age and older who have been recently diagnosed with AL amyloidosis. If you are interested, please continue below and complete the questionnaire to determine your eligibility.

Learn more about the CARES Studies.

Study Participation

The total duration of participation in the CARES Studies will be at least 52 weeks and consists of:


Study Treatment

Open-Label Extension Treatment